An observational study in Eyelid Diseases, sponsored by Benha University. Recruiting at 1 site in United Arab Emirates. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-18.
Sponsored by Benha University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Brow ptosis is a common problem. internal browbexy and brassier suture are common surgical approach
upper eye transcutaneous blepharoplasty then combined browbexy and brassier suture are done
26 studies on the registry are indexed under Eyelid Diseases; 4 are open to participants now.
Browse Eyelid Diseases studies →Benha University is the lead sponsor of 365 studies on the registry; 67 are open to participants now.
Counted across the registry records on this site, refreshed daily.
At least 18 years with dermatochalasis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
internal browbexy and brassier suture were done after blepharoplasty
global aesthetic scale
calculate scale score from score 1 exceptional improvement to 5 worsening patient
Time frame: 1 year
Started Jan 2021 (actual). Primary completion is estimated for Jul 2024, 42 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.